Aspirin might reduce recurrence risk for breast cancer survivors, study finds

Women who took aspirin two to five days per week were 60% less likely to have a recurrence and 71% less likely to die from the disease. But researchers caution that the results are preliminary. Women who take aspirin regularly after their breast cancer goes into remission are about 50% less likely to suffer a recurrence or to die from the disease, according...

Read the whole article on LA Times - Health

More from LA Times - Health